FI954499A - Menetelmä ja analyysi - Google Patents

Menetelmä ja analyysi Download PDF

Info

Publication number
FI954499A
FI954499A FI954499A FI954499A FI954499A FI 954499 A FI954499 A FI 954499A FI 954499 A FI954499 A FI 954499A FI 954499 A FI954499 A FI 954499A FI 954499 A FI954499 A FI 954499A
Authority
FI
Finland
Prior art keywords
pct
sec
date
analysis
procedure
Prior art date
Application number
FI954499A
Other languages
English (en)
Swedish (sv)
Other versions
FI113206B (fi
FI954499A0 (fi
Inventor
Nils Olav Solum
Frank Brosstad
Paol Andre Holme
Geir Olav Gogstad
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI954499(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of FI954499A publication Critical patent/FI954499A/fi
Publication of FI954499A0 publication Critical patent/FI954499A0/fi
Application granted granted Critical
Publication of FI113206B publication Critical patent/FI113206B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicinal Preparation (AREA)
  • Holo Graphy (AREA)
  • Telephone Function (AREA)
FI954499A 1993-03-24 1995-09-22 Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus FI113206B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939306053A GB9306053D0 (en) 1993-03-24 1993-03-24 Method and assay
GB9306053 1993-03-24
GB9400592 1994-01-14
PCT/GB1994/000592 WO1994022018A1 (en) 1993-03-24 1994-03-23 Method and assay

Publications (3)

Publication Number Publication Date
FI954499A true FI954499A (fi) 1995-09-22
FI954499A0 FI954499A0 (fi) 1995-09-22
FI113206B FI113206B (fi) 2004-03-15

Family

ID=10732620

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954499A FI113206B (fi) 1993-03-24 1995-09-22 Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus

Country Status (13)

Country Link
US (1) US5811250A (fi)
EP (1) EP0694168B2 (fi)
JP (1) JP3422491B2 (fi)
AT (1) ATE154847T1 (fi)
AU (1) AU691489B2 (fi)
CA (1) CA2158363C (fi)
DE (1) DE69403961T3 (fi)
DK (1) DK0694168T4 (fi)
ES (1) ES2103582T5 (fi)
FI (1) FI113206B (fi)
GB (1) GB9306053D0 (fi)
NO (1) NO953770L (fi)
WO (1) WO1994022018A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
NO20031431D0 (no) * 2003-03-28 2003-03-28 Forskningsparken As Metode for å diagnostisere hemostatiske forstyrrelser ved bruk av mikrovesikler fra blodplater
ES2571929T3 (es) * 2004-05-26 2016-05-27 Region Nordjylland Procedimiento para determinar la cantidad de CD36 circulante
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
CN101627135B (zh) * 2007-02-05 2013-04-10 北日德兰大区 通过测量cd36诊断动脉粥样硬化斑块的方法
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
CN102084000B (zh) * 2008-02-01 2016-03-16 总医院有限公司 微泡在医学疾病和病况的诊断、预后以及治疗中的用途
IT1398680B1 (it) * 2009-06-12 2013-03-08 Bios Internat S R L Metodo in vitro per la determinazione della proteina gp91phox come marker di stress ossidativo
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
WO2011084791A2 (en) 2009-12-21 2011-07-14 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-vegf treatment
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
WO2012064993A1 (en) 2010-11-10 2012-05-18 Exosome Diagnosties, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities

Also Published As

Publication number Publication date
GB9306053D0 (en) 1993-05-12
AU6262794A (en) 1994-10-11
NO953770D0 (no) 1995-09-22
ATE154847T1 (de) 1997-07-15
ES2103582T5 (es) 2002-12-16
FI113206B (fi) 2004-03-15
CA2158363A1 (en) 1994-09-29
DE69403961D1 (de) 1997-07-31
EP0694168A1 (en) 1996-01-31
CA2158363C (en) 2004-08-17
EP0694168B1 (en) 1997-06-25
WO1994022018A1 (en) 1994-09-29
DK0694168T3 (da) 1997-07-21
JP3422491B2 (ja) 2003-06-30
US5811250A (en) 1998-09-22
FI954499A0 (fi) 1995-09-22
DE69403961T2 (de) 1998-01-02
DK0694168T4 (da) 2002-09-30
EP0694168B2 (en) 2002-06-12
NO953770L (no) 1995-09-22
ES2103582T3 (es) 1997-09-16
AU691489B2 (en) 1998-05-21
DE69403961T3 (de) 2003-01-16
JPH08509806A (ja) 1996-10-15

Similar Documents

Publication Publication Date Title
FI954499A (fi) Menetelmä ja analyysi
NO923821L (no) Diagnostiske midler
JPS5726119B2 (fi)
NO950594L (no) Fremgangsmåte for diagnostisering og overvåking av sepsis
DE3851958D1 (de) VERFAHREN UND VORRICHTUNG ZUR BEHANDLUNG VON KöRPERLICHEN FLÜSSIGKEITEN.
BR9611909A (pt) Sistema de tratamento de água de ponto de utilização
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
SE9404196D0 (sv) New antithrombotic formulation
DE69619236D1 (de) Überwachungsverfahren
ATE208019T1 (de) Ventil für flüssigkeiten
HK1014207A1 (en) Method for quantifying extracellular bpi in body fluids
DE69624004D1 (de) Anordnung zur kontinuierlichen messung des herzminutenvolumens
ATE136940T1 (de) Diagnostische methode
DE3863188D1 (de) Mittel zur eliminierung von chloramin.
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
Caissie et al. Suspended sediment analysis for three P. E. I. streams using sediment rating curves.
DE69526490T2 (de) Verfahren und vorrichtung zur in erster linie ambulanten erfassung von verdauungsparametern
IT8963261V0 (it) Provetta o cuvetta ad uso apparecchio per l'analisi chimica, biomedica e per la sedimentazione.

Legal Events

Date Code Title Description
MA Patent expired